Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma

Acta Radiologica, Supplement

Volumn 39, Issue 417, 1998, Pages 7-36

  Rodriguez, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; METHIONINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOMA; CLASSIFICATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FORECASTING; GASTROSCOPY; HUMAN; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROGNOSIS; REMISSION; SCINTISCANNING; STOMACH TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; FORECASTING; GASTROSCOPY; HUMANS; LYMPHOMA, HIGH-GRADE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; METHIONINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROGNOSIS; RADIOPHARMACEUTICALS; REMISSION INDUCTION; STOMACH NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031614720     PISSN: 03655954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (125)

1. MAGRAT I. T.: The non-Hodgkin's lymphomas. E. Arnold, Hodder and Stoughton Ltd., Sevenoaks Kent, UK 1990.
2. ALBERTS B., BRAY D., LEWIS J., RAFF M., ROBERTS K. & WATSON J. D.: Molecular biology of the cell, ch. 18., 2nd edn. Garland Publ. Inc., New York 1989.
3. COOPER M. & LAWTON A.: The development of the immune system. Sci. Am. 231 (1974), 59.
4. LISTER A. T. & ARMITAGE J. O.: Non-Hodgkin's lymphoma. In: Diagnostic oncology, ch. 88. Edited by A. T. Skarin. Gower Med. Publ., New York 1991.
5. MELBYE M., ADAMI H. O., HJALGRIM H. & GLIMELIUS B.: Ultraviolet light and non-Hodgkin's lymphoma. Acta Oncol. 35 (1996), 655.
6. ADAMI J.: Non-Hodgkin's lymphoma. A search for causes. Thesis, Stockholm 1997.
7. LEVINE P. H. & HOOVER R. N. (editors): The emerging epidemic of non-Hodgkin's lymphoma. Current knowledge regarding etiological factors. Cancer Res. 52 (1992), Suppl., p. 5425.
8. SANDLER R. S.: Has primary gastric lymphoma become more common? J. Clin. Gastroenterol. 6 (1984), 193.
9. HAYES J. & DUNN E.: Has the incidence of primary gastric lymphoma increased? Cancer 63 (1989), 2073.
10. SEVERSON R. K. & DAVIS S.: Increasing incidence of primary gastric lymphoma. Cancer 66 (1990), 1283.
11. AISENBERG A. C.: Coherent view on Non-Hodgkin's lymphoma. J. Clin. Oncol. 13 (1995), 2656.
12. GALL E. & MALLORY T.: Malignant lymphoma. A clinical pathological survey of 618 cases. Am. J. Pathol. 18 (1942), 381.
13. RAPPAPORT H., WINTER W. & HICKS E.: Follicular lymphomas. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9 (1956), 792.
14. GÉRARD-MARCHANT R., HAMLIN I., LENNERT K., RILKE F., STANSFELD A. & VAN UNNIK J.: Classification of non-Hodgkin's lymphomas. Lancet 2 (1974), 406.
15. LUKES R. J. & BUTTLER J. J.: Pathology and nomenclature of Hodgkin's disease. Cancer Res. 26 (1966), 1063.
16. ROSENBERG S. A., BERARD C. & BROWN B.: National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. The non-Hodgkin's pathologic classification project. Cancer 49 (1982), 2112.
17. STANSFELD A., DIEBOLD J., KAPANCY Y. et al.: Updated Kiel classification for lymphomas. Lancet (1988), 292.
18. GAIDANO G., PASTORE C. & VOLPE G.: Molecular pathogenesis of the non-Hodgkin's lymphoma. A clinical perspective. Haematology 80 (1995), 454.
19. MEUSERS P., HENSE J. & BRITTINGER G.: Mantle cell lymphoma. Diagnostic criteria, clinical aspects and therapeutic problems. Leukemia 11 (1997), Suppl. 2, p. 60.
20. ZUCCA E. & ROGGERO E.: Biology and treatment of MALT lymphoma. The state of the art in 1996. A workshop at the 6th International Conference on Malignant Lymphoma. Ann. Oncol. 7 (1996), 787.
21. HARRIS N. L., JAFFE E. S., STEIN H. et al.: A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 84 (1994), 1361.
22. JAFFE E. S.: Introduction to the WHO classification. (Abstract.) Am. J. Surg. Pathol. 21 (1997), 114.
23. HORNING S. J.: Low-grade lymphoma 1993. State of the art. Ann. Oncol. 5 (1993), Suppl. 2, p. 23.
24. KIMBY E., BJORKHOLM M., GAHRTON G. et al.: Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas. A randomized trial from the Lymphoma Group of Central Sweden. Ann. Oncol. 5 (1994), Suppl. 2, p. 67.
25. ARMITAGE J. O.: Treatment of non-Hodgkin's lymphoma. N. Engl. J. Med. 328 (1993), 1023.
26. OTTENSMEIER C. & MEAD G.: Histological transformation of indolent (follicular) lymphoma. Ann. Oncol. 7 (1996), 849.
27. REHN S., GLIMELIUS B. & SUNDSTRÖM C. A.: A comparative study of proliferation-associated parameters in B-cell non-Hodgkin's lymphomas. Hematol. Oncol. 9 (1991), 287.
28. COIFFER B.: Fourteen years of high-dose CHOP (ACVB regimen). Preliminary conclusions about the treatment of aggressive lymphoma patients. Ann. Oncol. 6 (1995), 211.
29. DEVITA V. T. & HELLMAN S.: Hodgkin's disease and the non-Hodgkin's lymphomas. In: Cancer. Principles and practice of oncology, 2nd edn., p. 1331. Edited by V. T. De Vita et al. J. B. Lippincott, Philadelphia 1985.
30. CARBONE P. P., KAPLAN H. S., MUSSHOFF K. et al.: Report of the Committee in Hodgkin's disease staging classification. Cancer Res. 31 (1971), 1860.
31. KAPLAN H. S.: Hodgkin's disease. 2nd edn. Harvard University Press, Cambridge, MA 1980.
32. ROSENBERG S. A.: Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat. Rep. 61 (1977), 1023.
33. KAPLAN H.: Hodgkin's disease. Biology, treatment, prognosis. Blood 57 (1981), 813.
34. ROSENBERG S. A., DORFMAN R. & KAPLAN H.: The value of sequential bone marrow biopsy, laparotomy and splenectomy in a series of 127 consecutive untreated patients with non-Hodgkin's lymphoma. Br. J Cancer 31 (1975), Suppl. 2, p. 221.
35. EDDLESTON B. & AYERS A. B.: Reticuloendothelial disorders. Lymphoma. In: Diagnostic radiology. An Anglo-American textbook of imaging, 2nd edn., ch. 106. Churchill Livingstone Inc., New York 1992.
36. POND G. D., CASTELLINI R. A., HORNING S. & HOPPE R. T: Non-Hodgkin's lymphoma. Influence of lymphography, CT and bone marrow biopsy on staging and management. Radiology 170 (1989), 159.
37. CHISIN R. & WEBER A. L.: Imaging of lymphoma manifestations in the extracranial head and neck region. Leuk. Lymphoma 12 (1994), 177.
38. SALONEN O., KIVISAARI L., STANDERTSKJÖLD-NORDENSTAM C.-G., OKSANEN K. & LAPPALAINEN K.: Chest radiography and computed tomography in the evaluation of mediastinal adenopathy in lymphoma. Acta Radiol. 28 (1987), 747.
39. MüLLER N. L., WEBB W. R. & GAMSU G.: Subcarinal lymph node enlargement. Radiographic findings and CT correlation. AJR 145 (1985), 15.
40. BONOMO L., CICCOTOSTO C., GUIDOTI B., MERLINO B. & STORTO M. L.: Staging of thoracic lymphoma by radiological imaging. Eur. Radiol. 7 (1997), 1179.
41. CASTELLINO R. A., HOPPE R., BLANK N. et al.: Computed tomography, lymphography and staging laparotomy. Correlations in initial staging of Hodgkin's disease. AJR 143 (1984), 37.
42. STRIJK S. P., BOETES C., ROSENBUSCH G. & RUIS J. H.: Lymphography and abdominal computed tomography in staging Hodgkin's disease. RÖFO 146 (1987), 312.
43. BRASCO D. J.: Hodgkin's disease and non-Hodgkin's lymphoma. In: Abdominal ultrasound in the cancer patient. Edited by D. J. Brasco & T. H. Strawber. Wiley, New York 1980.
44. MAC VICAR D. & HUSBAND J. E.: Reticuloendothelial disorders. Lymphoma. In: Grainger & Allison's diagnostic radiology. A textbook of medical imaging, 3rd edn., ch. 109 A. Churchill Livingstone, New York 1997.
45. INGRAM C. E., BELL A. M., LEWARS M. D. et al.: Normal lymph node size in the mediastinum. A restrospective study in two patient groups. Clin. Radiol. 40 (1989), 35.
46. DORFMAN R. E., ALPERN M. B., GOSS B. J. & SANDLER M. A.: Upper abdominal lymph nodes. Criteria of normal size determined with CT. Radiology 180 (1991), 319.
47. VINNICOMBE S. J., NORMAN A. R., NICOLSON V. & HUSBAND J. E.: Normal pelvic lymph nodes.Evaluation with CT after bipedal lymphangiography. Radiology 194 (1995), 349.
48. JENKINS P. F., WARD M. J., DAVIES P. et al.: Non-Hodgkin's lymphoma, chronic lymphocytic leukemia and the lung. Br. J. Dis. Chest 75 (1981), 22.
49. CARLSEN S. E., BERGIN C. J. & HOPPE R. T: MR imaging to detect chest wall and pleural involvement in patients with lymphoma. Effect on radiation therapy planning. AJR 160 (1993), 1191.
50. SANDRASEGARAN K., ROBINSON P. J. & SELBY P.: Staging of lymphoma in adults. Clin. Radiol. 49 (1994), 149.
51. KLINE T. S. & GOLDSTEIN F.: Malignant lymphoma involving the stomach. Cancer 32 (1973), 961.
52. BUSH R. S. & ASH C. L.: Primary lymphoma of the gastrointestinal tract. Radiology 92 (1969), 1349.
53. MARSHAK R. H., LINDNER A. E. & MAKLANSKY D.: The radiology corner. Lymphosarcoma of the stomach. Am. J. Gastroenterol. 66 (1976), 176.
54. BALFE D. M. KOEHLER R. E., KARSTEADT N., STANLEY R. J. & SAGEL S. S.: Computed tomography of gastric neoplasms. Radiology 140 (1981), 431.
55. CARROLL B. A. & TA H. N.: The ultrasonographic appearance of the extranodal abdominal lymphoma. Radiology 136 (1980), 419.
56. SASAI K., YAMABE H., TSUTSUI K. et al.: Primary testicular non-Hodgkin's lymphoma. A clinical study and review of the literature. Am. J. Clin. Oncol. 20 (1997), 59.
57. SCHAJOWITZ F.: Tumors and tumor like lesions of bone and joints. Springer-Verlag, New York 1981.
58. NYMAN R., REHN S., GLIMELIUS B. et al.: Magnetic resonance imaging in diffuse malignant bone marrow diseases. Acta Radiol. 28 (1987), 199.
59. SCHWAIGHOFER B. W., HESSELINK J. R., PRESS G. A. et al.: Primary intracranial CNS lymphoma. MRI manifestations. AJNR 10 (1989), 725.
60. BROWNELL G. L., CORREIA J. A. & ZAMENHOF R.: Positron instrumentation. In: Recent advances in nuclear medicine, p. 1. Edited by J. H. Lawrence & T. F. Budinger, Grune & Stratton, New York 1978.
61. PHELS M. E., MAZZIOTTA J. C. & SCHELBERT H. R. (editors): Positron emission tomography and autoradiography. Raven Press, New York 1986.
62. STRAUSS L. G. & CONTI P. S.: The applications of PET in clinical oncology. J. Nucl. Med. 32 (1991), 623.
63. HAMACHER K., COENEN H. H. & STÖCKLIN G.: Efficient stereospecific synthesis of no-carrier-added 2-(18F)-fluoro-2-deoxy D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 27 (1986), 235.
64. 11C) methionine. J. Nucl. Med. 28 (1987), 1037.
65. LESKINEN-KALLIO S., RUOTSALAINEN U., NÅGREN K., TERS M. & JOENSUU H.: Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma. A PET study. J. Nucl. Med. 32 (1991), 1211.
66. OKADA J., YOSHIKAWA K., ITAMI M. et al.: Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma. A comparison with proliferative activity. J. Nucl. Med. 33 (1992), 325.
67. OKADA J., YOSHIKAWA K., IMASEKI K. et al.: The use of FDG PET in the detection and management of malignant lymphoma. Correlation of uptake with prognosis. J. Nucl. Med. 32 (1991), 686.
68. MILLER T. P., LIPPMAN S. M., SPIER C. M., SLYMEN D. J. & GROGAN T. M.: HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J. Clin. Invest. 82 (1988), 370.
69. SWAN F., HUH Y., KATZ R., CABANILLAS F., RODRIGUEZ M. & EPSTEIN J.: Beta-2-microglobulin (β2M) and HLA-DR cellular expression in relapsing large cell lymphomas (LCL). Relationship to survival and serum β2M levels. (Abstract.) Blood 1976 (1990), Suppl. 375a.
70. OFFIT K. & CHAGANTI R. S. K.: Chromosomal aberrations in non-Hodgkin's lymphoma. Biological and clinical correlations. Hematol. Oncol. Clin. North Am. 5 (1991), 853.
71. REHN S., NYMAN R., GLIMELIUS B., HAGBERG H. & SUNDSTRÖM C.: Non-Hodgkin's lymphoma. Predicting prognostic grade with MR imaging Radiology 176 (1990), 249.
72. REHN S., SPERBER G. O., NYMAN R., GLIMELIUS B., HAGBERG H. & HEMMINGSSON A.: Quantification of inhomogeneities in malignancy grading of non-Hodgkin's lymphomas with MR imaging. Acta Radiol. 34 (1993), 3.
73. KNAUP W., LANGENMAYER I., NERL C. et al.: Interferon-alfa 2 b early phase chronic lymphocytic leukemia with high risk for progression. First results of a randomized multicenter AIO-study. Onkologie 15 (1992), 55.
74. ZIEGLER-HEITBROCK H. W. L., SCHLAG R., FLIEGER D. & THIEL E.: Favorable response of early stage B CLL patients to treatment with IFN-alpha 2. Blood 73 (1989), 1426.
75. AISENBERG A. C.: An historical overview of malignant lymphomas. In: Neoplastic diseases of the blood, 2nd edn., p. 597. Edited by P. H. Wiernik et al. Churchill Livingstone, New York 1991.
76. LEE J. T. K., STANLEY R. J., SAGEL S. S. et al.: Limitations of the post-lymphangiogram plain abdominal radiograph as an indicator of recurrent lymphoma. Comparison to the computed tomography. Radiology 134 (1980), 155.
77. BLACKLEDGE G., MAMTORA H., CROWTHER D. et al.: The role of computed tomography in lymphoma following treatment. Br. J. Radiol. 54 (1981), 955.
78. SWEETENHAMN J., MEAD G., WHITEHOUSE J. et al.: Residual abdominal masses following intensive weekly chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). (Abstract.) Br. J. Cancer 62 (1990), 625.
79. TREDANIEL J., LEPAGE E., FRIJA J. et al.: Les masses résiduelles après chimotérapie des lymphomes non-Hodkiniens. Nouv. Rev. Fr. Hematol. 30 (1988), 75.
80. HUSBAND J. E.: Imaging of treated cancer. (Mackenzie Davidson memorial lecture 1994.) Br. J. Radiol. 68 (1995), 599.
81. SURBONE A., LONGO D. .L, DEVITA V. T. et al.: Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy. Significance and management. J. Clin. Oncol. 6 (1988), 1832.
82. TREDANIEL J., BRICE P., LEPAGE E. et al.: The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas. Eur. Respir. J. 5 (1992), 170.
83. BRICE P., RAIN J. D., FRIJA J. et al.: Residual mediastinal mass in malignant lymphoma. Value of magnetic resonance imaging and gallium scan. Nouv. Rev. Fr. Hematol. 35 (1993), 457.
84. HILL M., CUNNINGHAM D., MAC VICAR D. et al.: Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J. Clin. Oncol. 11 (1993), 2273.
85. RHAMOUNI A., TEMPANY C., JONES R. et al.: Lymphoma. Monitoring tumor size and signal intensity with MR imaging. Radiology 188 (1993), 445.
86. NEDELLEC G., LIOURE E., BUSSY E. et al.: Evaluation of residual masses after lymphoma treatment. The contribution of gallium 67 tomoscintigraphy. Nouv. Rev. Fr. Hematol. 32 (1990), 187.
87. BRICE P., RAIN J. D. & FRIJA J.: Value of imaging for the diagnosis of residual mediastinal mass in malignant lymphomas. Nouv. Rev. Fr. Hematol. 33 (1991), 531.
88. NEWMAN J. S., FRANCIS I. R., KAMINSKI M. S. & WAHL R. L.: Imaging of lymphoma with PET with 2-(F-18)-fluoro-2-deoxy-D-glucose. Correlation with CT. Radiology 190 (1994), 111.
89. JERKEMAN M., CAVALLIN-STÅHL E., HAGBERG H. et al.: CHOP versus MACOP-B in aggressive non-Hodgkin's lymphoma - a prospective, randomized trial by the Nordic Lymphoma Group. Manuscript (1998).
90. HAGBERG H., LINDEMALM C. & CAVALLIN-STÅHL C. et al. (The Swedish Lymphoma Study Group): CHOP versus CHOP-M in the treatment of high-grade malignant non-Hodgkin's lymphomas in adults. A Swedish national randomized study. Proc. ASCO 7 (1998), 243.
91. KLIMO P. & CONNORS J.: MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann. Intern. Med. 102 (1985), 596.
92. KOPS E. R., HERZOG H., SCHMID A., HOLTE S. & FEINENDEGEN L. E.: Performance characteristics of an eight-ring whole boy PET scanner. J. Comput. Assist. Tomogr. 14 8 (1990), 437.
93. TOOROGIAN S. A. MULHOLLAND G. K., JEWETT D. M. et al.: Routine production of 2-deoxy-2-(18F)fluoro-D-glucose by direct nucleophilic exchange on a quanternary 4-aminopyridinium resin. Int. J. Rad. Appl. Instrum. 17 (1990), 273.
94. ABUMRAD N. N., RABIN D., DIAMOND M. P. & LACY W. W.: Use of a heated superficial hand vein as an alternative site for the measurements of amino acid concentration and for the study of glucose and alanine kinetics in man. Metabolism 30 (1981), 936.
95. SHIPP M. A., HARRINGTON D. P., ANDERSSON J. R. et al.: A predictive model for aggressive non-Hodgkin's lymphoma. New Engl. J. Med. 329 (1993), 987.
96. BERGSTRÖM M., ERIKSSON L., BOHM C., BLOMQVIST G. & LITTON J.: Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J. Comput. Assist. Tomogr. 7 (1983), 42.
97. PATLAK C. S., BLASBERG R. G. & FENSTERMACHER J. D.: Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3 (1983), 1.
98. HATAZAWA J., ISHIWATA K., ITOH M. et al.: Quantitative evaluation of L-(methil-C-11)-methionine uptake in tumor using positron emission tomography. J. Nucl. Med. 30 (1989), 1809.
99. F) fluorodeoxyglucose. J. Cereb. Blood Flow Metab. 10 (1990), 180.
100. Cox D R.: Regression models and life tables (with discussion). J. R. State Soc. B. 34 (1972), 187.
101. RÜSSEL D. & RUBINSTEIN L.: Pathology of tumours of the nervous system. 5th edn., p. 219. Edward Arnold, London 1989.
102. TUBIANA M.: Repopulations in humans tumors. A biological background for fractionation in radiotherapy. Acta Oncol. 27 (1988), 83.
103. CANELLOS G. P.: Residual mass in lymphoma may not be residual disease. J. Clin. Oncol. 6 (1988), 931.
104. LEWIS E., BERNARDINO M. E., SALVADOR P. G. et al.: Post-therapy CT-detected mass in lymphoma patients. Is it viable tissue? J. Comput. Assist. Tomogr. 6 (1982), 792.
105. STEWARD F. M., WILLIAMSON B. R., INNES D. J. et al.: Residual tumor masses following treatment for advanced histiocytic lymphoma. Diagnostic and therapeutic implications. Cancer 55 (1985), 620.
106. BURGENER S. A. & HAMLIN D. J.: Histiocytic lymphoma of the abdomen. Radiographic spectrum. AJR 137 (1981), 337.
107. NYMAN R., REHN S., GLIMELIUS B., HAGBERG H., HEMMINGSSON A. & SUNDSTRÖM C.: Residual mediastinal masses in Hodgkin disease. Prediction of size with MR imaging. Radiology 170 (1989), 435.
108. ARMITAGE J. O., WEISENBURGER D. D., HUTCHINS M. et al.: Chemotherapy for diffuse large cell lymphoma-rapidly responding patients have more durable remissions. J. Clin. Oncol. 4 (1986), 160.
109. JANICEK M., KAPLAN W., NEUBERG D,. CANELLOS G. P., SHULMAN L. N. & SHIPP M. A.: Early restaging gallium scans predict outcome in poor-prognosis patients with agressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J. Clin. Oncol. 15 (1997), 1631.
110. HORWICH A., PALUCHOWSKA B., NORMAN A. et al.: Residual mass following chemotherapy of semionoma. Ann. Oncol. 8 (1997), 37.
111. LAPELA M., LESKINEN S., MINN H. R. et al.: Increased glucose metabolism in untreated non-Hodgkin's lymphoma. A study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 86 (1995), 3522.
112. F) fluorodeoxyglucose in brain tumors - a powerful diagnostic and prognostic tool. Invest. Radiol. 22 (1986), 360.
113. LINDHOLM P., LESKINEN-KALLIO S., MINN H. et al.: Comparison of fluorine 18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. J. Nucl. Med. 34 (1993), 1711.
114. ANDERSON K. C., LEONARD R. C., CANELLOS G. P. et al.: High dose gallium imaging in lymphoma. Am. J. Med. 75 (1981), 327.
115. BEN-HAIM S., BAR-SHALOM R., ISRAEL O. et al.: Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma. J. Clin. Oncol. 14 (1996), 1936.
116. LARSSON S. M., MILDER M. S. & JOHNSTON G. S.: Interpretation of the gallium photoscan. J. Nucl. Med. 14 (1973), 208.
117. MITTAL B., WASSERMAN T. H. & GRIFFITH R. C.: Non-Hodgkin lymphoma of the stomach. Am. J. Gastroenterol. 78 (1983), 780.
118. BUY J. N. & MOSS A. A.: Computed tomography of gastric lymphoma. AJR 138 (1982), 859.
119. MOOG F., BANGERTER M., DIEDERICHS C. et al.: Lymphoma. Role of whole-body 2-deoxy-2-[F-18] fluoro-D-glucose (FDG)PET in nodal staging. Radiology 203 (1997), 795.
120. HOH C. K., GLASPY J., ROSEN P. et al.: Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J. Nucl. Med. 38 (1997), 343.
121. RODRIGUEZ M., REHN S., AHLSTRÖM H., SUNDSTRÖM C. & GLIMELIUS B.: Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J. Nucl. Med. 36 (1995), 1790.
122. EIKMAN E. A., TENORIO L. E., FRANK B. A. et al.: Gallium-67 accumulation in the stomach in patients with postoperative gastritis. J. Nucl. Med. 21 (1980), 706.
123. MACMAHON H., VYBORNY C., SEPHARDARI S. et al.: Gallium accumulation in the stomach a frequent incidental finding. Clin. Nucl. Med. 10 (1985), 719.
124. SCHUDER G., HILDEBRANDT U., KREISSLER-HAAG D., SEITZ G. & FEIFEL G.: Role of endosonography in the surgical management of non-Hodgkin's lymphoma of the stomach. Endoscopy 25 (1993), 509.
125. TIO T. L., DEN HARTOG JAGER F. C. A. & TYGAT G. N. J.: Endoscopic ultrasonography in detection and staging of gastric non-Hodgkin lymphoma. Scand. J. Gastroenterol. 21 (1986), Suppl. 123, p. 52.